McCamish Mark Anthony

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 31% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 160%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
McCamish Mark Anthony's trades of Avadel Pharmaceuticals PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
133.27
Quantity 81,329
Value US$4,436,488
Transaction date
Proposed sale
Price
14.88
Quantity 28,975
Value US$431,154
Transaction date
Sale
Price
95.42
Quantity 30,237 -86.8%
Value US$2,885,236
Transaction date
Sale
Price
95.41
Quantity 2,340 -6.3%
Value US$223,268
Transaction date
Planned sale
Price
11.02
Quantity 8,199 -11.9%
Value US$90,391
Transaction date
Planned sale
Price
11.04
Quantity 8,301 -12.0%
Value US$91,626
Transaction date
Planned sale
Price
12.46
Quantity 1,291 -2.1%
Value US$16,080
Transaction date
Planned sale
Price
12.07
Quantity 15,209 -20.0%
Value US$183,646
Transaction date
Planned sale
Price
18.12
Quantity 16,500 -21.4%
Value US$299,054
Transaction date
Planned sale
Price
18.15
Quantity 16,500 -21.4%
Value US$299,401
Transaction date
Planned sale
Price
14.94
Quantity 9,410 -13.4%
Value US$140,546
Transaction date
Planned sale
Price
15.06
Quantity 7,090 -10.5%
Value US$106,797
Transaction date
Planned sale
Price
14.59
Quantity 20,000 -68.9%
Value US$291,892
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-29 2023-12-28
PlS Planned sale
55,362 -29.8%
106.12
US$1,595,182 		55,362 -29.8% 106.12 US$1,595,182
2023-12-28 2023-12-28
PrS Proposed sale
81,329
133.27
US$4,436,488 		81,329 133.27 US$4,436,488
2023-08-15 2023-08-11
S Sale
93,480 -6.3%
178.74
US$4,758,994 		93,480 -6.3% 178.74 US$4,758,994
2023-08-11 2023-08-11
PrS Proposed sale
28,975
14.88
US$431,154 		28,975 14.88 US$431,154
2020-09-18 2020-09-17
B Purchase
52,398 +44.2%
5.83
US$305,250 		52,398 +44.2% 5.83 US$305,250
2020-09-18 2020-09-16
B Purchase
118,602 New position
5.73
US$679,969 		118,602 New position 5.73 US$679,969
2020-04-03 2020-04-01
S Sale
30,237 -86.8%
95.42
US$2,885,236 		30,237 -86.8% 95.42 US$2,885,236
2020-04-03 2020-04-01
S Sale
2,340 -6.3%
95.41
US$223,268 		2,340 -6.3% 95.41 US$223,268
2019-06-27 2019-06-25
PlS Planned sale
8,199 -11.9%
11.02
US$90,391 		8,199 -11.9% 11.02 US$90,391
2019-06-24 2019-06-20
PlS Planned sale
8,301 -12.0%
11.04
US$91,626 		8,301 -12.0% 11.04 US$91,626
2019-05-22 2019-05-20
PlS Planned sale
1,291 -2.1%
12.46
US$16,080 		1,291 -2.1% 12.46 US$16,080
2019-05-22 2019-05-20
PlS Planned sale
15,209 -20.0%
12.07
US$183,646 		15,209 -20.0% 12.07 US$183,646
2019-04-22 2019-04-18
PlS Planned sale
16,500 -21.4%
18.12
US$299,054 		16,500 -21.4% 18.12 US$299,054
2019-03-21 2019-03-19
PlS Planned sale
16,500 -21.4%
18.15
US$299,401 		16,500 -21.4% 18.15 US$299,401
2019-02-21 2019-02-20
PlS Planned sale
9,410 -13.4%
14.94
US$140,546 		9,410 -13.4% 14.94 US$140,546
2019-02-21 2019-02-19
PlS Planned sale
7,090 -10.5%
15.06
US$106,797 		7,090 -10.5% 15.06 US$106,797
2019-01-23 2019-01-18
PlS Planned sale
20,000 -68.9%
14.59
US$291,892 		20,000 -68.9% 14.59 US$291,892